We recently showed that the DNA methylation alterations of CD34+CD15− chronic myeloid leukaemia (CML) cells affect alternative splicing genes, suggesting that spliceosome actors might be altered in chronic-phase (CP)-CML. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.